Indaptus Therapeutics CFO Steps Down, Board Adds Director Indaptus filed an SEC 8-K on Apr 3, 2026 reporting a CFO transition and one new board appointment; monitor 8-K amendments over the next 30–90 days.

Indaptus Therapeutics CFO Steps Down, Board Adds Director: Indaptus filed an SEC 8-K on Apr 3, 2026 reporting a CFO transition and one new board appointment; monitor 8-K amendments over the next… 👈 Read full analysis #IndaptusTherapeutics #CFOChange #CorporateGovernance #SECfiling #BoardOfDirectors